FALCO HOLDINGS Co., Ltd. (TYO:4671)

Market Cap	25.29B +3.6%
Revenue (ttm)	43.58B +0.6%
Net Income	2.02B +5.0%
EPS	200.06 +10.6%
Shares Out	10.01M
PE Ratio	12.63
Forward PE	n/a
Dividend	128.00 (5.05%)
Ex-Dividend Date	Mar 30, 2026

Volume	15,600
Open	2,523.00
Previous Close	2,536.00
Day's Range	2,500.00 - 2,541.00
52-Week Range	2,232.00 - 2,775.00
Beta	0.27
Analysts	n/a
Price Target	n/a
Earnings Date	May 12, 2026

About FALCO HOLDINGS

FALCO HOLDINGS Co., Ltd., a medical service company, provides clinical testing and dispensing pharmacy services to medical institutions and companies in Japan. The company offers clinical testing services in the fields of genetic tests, biochemistry, hematology, pathology, immunology, and microbiology; and genetic testing services. It also provides medical information technology services; and develops in vitro diagnostics for unmet medical needs. In addition, the company is involved in the dispensing pharmacies and drugstores business; and deve...

• Industry: Medical - Diagnostics & Research
• Sector: Healthcare
• Founded: 1962
• Employees: 1,062
• Stock Exchange: Tokyo Stock Exchange
• Ticker Symbol: 4671

Financial Performance

In fiscal year 2026, FALCO HOLDINGS's revenue was 43.58 billion, an increase of 0.61% compared to the previous year's 43.31 billion. Earnings were 2.02 billion, an increase of 5.00%.